Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2025 ,inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June, 2025